IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2006;47:1448-1457.)
© 2006 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.05-0299

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kitaoka, Y.
Right arrow Articles by Lam, T. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kitaoka, Y.
Right arrow Articles by Lam, T. T.

TNF-{alpha}-Induced Optic Nerve Degeneration and Nuclear Factor-{kappa}B p65

Yasushi Kitaoka,1,2 Yuka Kitaoka,1,2 Jacky M. K. Kwong,3 Fred N. Ross-Cisneros,1 Jiantao Wang,1 Rong Kung Tsai,4 Alfredo A. Sadun,1 and Tim T. Lam1

1From the Department of Ophthalmology, Doheny Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California; the 2Department of Ophthalmology, St. Marianna University School of Medicine, Kanagawa, Japan; the 3Department of Ophthalmology, Jules Stein Eye Institute, University of California Los Angeles School of Medicine, Los Angeles, California; and the 4Department of Ophthalmology, Buddhist Tzu Chi Medical Center, Buddhist Tzu Chi University, Hualien, Taiwan.

PURPOSE. To characterize a model of optic nerve axonal degeneration induced by tumor necrosis factor (TNF)-{alpha} and to determine the role of nuclear factor (NF)-{kappa}B p65 in axonal degeneration.

METHODS. Groups of rats were euthanatized at 1 day, 1 or 2 weeks, or 1 or 2 months after intravitreal injection of TNF-{alpha}. Morphometric analyses of neurofilament- or Thy-1-positive cells, retinal ganglion cells (flat preparations stained with cresyl violet or retrograde labeling with a neurotracer), the number of axons, immunostaining for myelin basic protein, and TUNEL assays were performed. Levels of NF-{kappa}B p65 protein in retina and optic nerve were determined by Western blot analysis and immunohistochemistry. The effects of antisense oligodeoxynucleotide (AS ODN) against NF-{kappa}B p65 and helenalin, an inhibitor of NF-{kappa}B p65 activation, on TNF-{alpha}-induced optic nerve degeneration were determined by counting the number of axons.

RESULTS. Intravitreal injections of TNF-{alpha} induced obvious axonal loss and extensive degeneration of the axons from 2 weeks to 2 months after injection, whereas significant retinal ganglion cell loss was noted only at 2 months after injection. NF-{kappa}B p65 was increased in the optic nerve but not in the retina and was found to colocalize with ED-1 and Iba1, markers of microglia. Inhibition of NF-{kappa}B p65 with AS ODN or helenalin significantly ameliorated the effects of TNF-{alpha}-mediated axonal loss.

CONCLUSIONS. TNF-{alpha} causes axonal degeneration with probable delayed loss of retinal ganglion cell bodies. NF-{kappa}B p65 may play a pivotal role in axonal degeneration, with the possible involvement of microglial cells.





This article has been cited by other articles:


Home page
J. Neurosci.Home page
T. Nakazawa, C. Nakazawa, A. Matsubara, K. Noda, T. Hisatomi, H. She, N. Michaud, A. Hafezi-Moghadam, J. W. Miller, and L. I. Benowitz
Tumor Necrosis Factor-{alpha} Mediates Oligodendrocyte Death and Delayed Retinal Ganglion Cell Loss in a Mouse Model of Glaucoma
J. Neurosci., December 6, 2006; 26(49): 12633 - 12641.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Association for Research in Vision and Ophthalmology